Region Zealand: we are there for you

Fri Jun 26 2020

By: Thomas Neil Skov, ViroGates

Region Zealand (RZ) is one of five regions in Denmark. The region has six hospitals, which annually takes care of approx. 190,000 admitted patients. A large emergency medical service set-up ensures prompt and local treatment.

On March 24 the Clinical Immunology Department at Næstved Hospital, the leading hospital in RZ, anchored the implementation of suPAR in clinical routine across the hospitals in the region (Fig. 1).

Region Zealand comprises the six hospitals Holbæk, Roskilde, Køge, Slagelse, Næstved and Nykøbing F. It is the Clinical Immunology Dept at Næstved Hospital which anchored the implementation of suPAR at regional level

Fig. 1. Region Zealand comprises the six hospitals Holbæk, Roskilde, Køge, Slagelse, Næstved and Nykøbing F. It is the Clinical Immunology Dept at Næstved Hospital which anchored the implementation of suPAR at regional level.

The original idea was for all the Clinical Immunology Departments in the region to use suPAR in order to address rheumatic diseases such as systemic lupus erythematosus (SLE). Fueled by the COVID-19 pandemic, however, it soon became practice to also be using suPAR for triaging of patients admitted with suspicion of the COVID-19 disease. The aim is now to expand the use of suPAR, currently measured using an aLF Reader (a point-of-care device, see Fig. 2), to also allow triage and monitoring of acute medical patients, as well as patients with other autoimmune diseases than SLE. These include diabetes, cardiovascular diseases, infectious diseases, and kidney diseases, where suPAR can assist in discharge decisions, as well as predict serious illness and increased risk of death.

suPAR measurements station. suPAR is currently measured using the aLF Reader

Fig. 2. suPAR measurements station. suPAR is currently measured using the aLF Reader

“The suPAR test will now be available for all departments within hospitals in RZ. The Department of Clinical Immunology offers the analysis, having brought forward the implementation due to the extraordinary COVID-19 pandemic.”

Medical Director of RZ Keld M. Homburg

+800

published suPAR studies in leading medical journals

Nature Medicine Logo
Science Journal Logo
JAMA Pediatrics Logo

The suPARnostic® brand consists of 3 products:

Photo of The suPARnostic® Quick Triage kit

Quick Triage

A Point of Care Solution

Photo of suPARnostic® TurbiLatex

TurbiLatex

For Automated Systems

Photo of suPARnostic® ELISA

ELISA Assay

Clinical and Research

suPAR is used in clinical routine in 38 hospitals

38 hospitals use suPAR in clinical routine for triage of patients in the Emergency Departments and COVID-19 units. Clinical routine is defined by the placement of two Purchasing Orders within the last 12 months rolling. This period covers October 1, 2021, until September 30, 2022.
Some hospital locations cannot be disclosed due to confidentiality.

New Webinar

Webinar

Catch COVID-19

-Improve your triage

Sign up to view webinar recording

View recording

suPARnostic® by ViroGates